PARP9 was identified as overexpressed in chemoresistant, diffuse large B-cell lymphomas (DLBCLs) [64], but there is no data concerning the implication of PARP9 in CC. The gene discussed is PARP9; the disease is diffuse large B-cell lymphoma.